SCHEMBL5772957

SCHEMBL5772957

Cn1nc2c(c1CCC(=O)O)CCCC2

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.55
MAPT P10636 2/20 0.55
TDP1 Q9NUW8 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
GAA P10253 4/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
CYP1A2 P05177 2/20 0.44
HTT P42858 3/20 0.37
ALDH1A1 P00352 2/20 0.37
RXRA P19793 1/20 0.35
RXRB P28702 1/20 0.35
RXRG P48443 1/20 0.35
KDM4E B2RXH2 2/20 0.34
HCAR2 Q8TDS4 1/20 0.34
POLQ O75417 2/20 0.33
LMNA P02545 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23082833 0.78 POLB (0.50) POLBMAPTTDP1L3MBTL1GAA
SCHEMBL3606808 0.76 GAA (0.52) POLBMAPTTDP1L3MBTL1GAA
SCHEMBL5774355 0.76 FABP4 (0.47) POLBALDH1A1RXRARXRBRXRG
SCHEMBL12871625 0.74 GAA (0.53) POLBMAPTTDP1L3MBTL1GAA
SCHEMBL3618209 0.73 POLB (0.47) POLBMAPTTDP1L3MBTL1GAA
SCHEMBL5773019 0.73 RXRA (0.46) MAPTRXRARXRBRXRG
SCHEMBL4770442 0.71 POLB (1.00) POLBMAPTTDP1L3MBTL1GAA
SCHEMBL24405748 0.70 POLB (0.96) POLBMAPTTDP1L3MBTL1GAA
SCHEMBL3794341 0.69 POLB (0.47) POLBMAPTTDP1L3MBTL1GAA
SCHEMBL23062881 0.68 POLB (0.93) POLBMAPTTDP1L3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885883-B1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF MITSUBISHI PHARMA CORP (JP) 2006-11-02 EP disclosed
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed